Latest Investment News

Botanix Pharmaceuticals reported a robust 28% increase in net revenue for Sofdra in Q2 FY26, driven by a 24% rise in prescriptions and a growing US sales team. The company maintains a strong cash position while navigating higher operating costs.

Brightstar Resources is progressing its Sandstone Gold Project with a maiden Ore Reserve and Pre-Feasibility Study on schedule, aiming to establish a district-scale, long-life gold production centre in Western Australia.

Canadian Phosphate Limited reported a solid cash position of AUD 2.44 million at the end of December 2025, supported by financing activities and ongoing preparations for bulk sample mining in Canada.

Odessa Minerals has identified multiple new base metal and gold prospects at its Lyndon Project through advanced hyperspectral mapping, supported by a recent $1.15 million capital raise to accelerate exploration.

Brazilian Critical Minerals has reported significant progress at its Ema rare earths project, producing a high-grade rare earth carbonate rich in critical magnet metals and advancing key drilling, permitting, and feasibility milestones.

Fitzroy River Corporation reported steady royalty income for the December 2025 quarter, while advancing key projects including a $40 million funding campaign for the Rafael Gas Project and a $150 million equity raise for Snowy River Gold development.

Jindalee Lithium Limited reported a cash outflow for the December 2025 quarter but maintains a solid cash position of A$6.5 million, with an estimated funding runway of 1.67 quarters. The company remains confident in securing additional financing to support its pre-development activities.

Prestal Holdings reports a significant 26.4% decline in revenue and a sharp fall in EBITDA for the first half of FY26, reflecting ongoing market challenges. Despite the downturn, the company maintains a strong cash position heading into the new year.

Ioneer Ltd has reported a significant uplift in the economics of its Rhyolite Ridge lithium-boron project, alongside ongoing strategic partnership talks and strong market demand for lithium and boric acid.

CD Private Equity Fund II announces a $0.38 per unit distribution reflecting recent portfolio realisations, delivering nearly double the initial investment in returns since inception.

CD Private Equity Fund I announces a $0.05 per unit distribution, bringing total returns close to twice the initial investment since inception.

Echo IQ has completed clinical validation of its EchoSolv HF heart failure detection software with the Mayo Clinic Platform, achieving outstanding accuracy. The company has now formally submitted its FDA 510(k) clearance application, positioning itself for significant commercial expansion in the US healthcare market.